Kendle to Present at UBS Global Life Sciences Conference

CINCINNATI, Sept. 16 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming UBS Global Life Sciences Conference on Sept. 21, 2009, at the Grand Hyatt New York Hotel in New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO )

Kendle's formal presentation will be given by Chairman and Chief Executive Officer Candace Kendle, PharmD, at 12:30 p.m. Eastern Time.

The presentation will be Webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=74_NFDSOWW.

Slides will be available by 10 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.

SOURCE Kendle International Inc.